The FDA has approved Medicis’ hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L. This approval was based on clinical data that demonstrated Restylane-L and Perlane-L to ...

SCOTTSDALE, Ariz., April 27, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration's (FDA) General and Plastic Surgery Devices Advisory Panel (the ...

- Galderma reinforces long-term commitment to meet physician and patient needs in aesthetic and corrective dermatology worldwide Restylane, Perlane and Emervel are manufactured by Galderma and sold by ...

Evolus dermal filler, Evolysse™ Lift, met primary endpoint of non-inferiority and demonstrated superiority to Restylane-L at 6 months; Secondary endpoints for improvement in nasolabial fold severity ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted market approval to Restylane Lyft with lidocaine for cheek augmentation and correction of ...

(MENAFN- PR Newswire) FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Defyne for the augmentation and ...

The FDA has approved Restylane® Kysse (Galderma) for lip augmentation and the correction of upper perioral rhytids in adults aged >21 years. The Food and Drug Administration (FDA) has approved ...

Men and nonsurgical facial procedures (i.e., in-office injectables, such as fillers like Restylane) are having a moment together—the numbers simply don't lie. Cosmetic surgery, as well as nonsurgical ...